SB

Sophie Beauchemin

AB AbbVie: 4 patents #436 of 1,308Top 35%
OT Ocera Therapeutics: 3 patents #12 of 37Top 35%
TP Tranzyme Pharma: 2 patents #16 of 19Top 85%
📍 Sherbrooke, CA: #60 of 670 inventorsTop 9%
Overall (All Time): #568,686 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10040751 Intermediates for macrocyclic compounds Eric Marsault, Kamel Benakli, Hamid R. Hoveyda, Mark L. Peterson, Sylvie Beaubien +2 more 2018-08-07
9371297 Macrocyclic ghrelin receptor modulators and methods of using the same Hamid R. Hoveyda, Graeme L. Fraser, Kamel Benakli, Martin Brassard, Eric Marsault +3 more 2016-06-21
9181298 Intermediates for macrocyclic compounds Eric Marsault, Kamel Benakli, Hamid R. Hoveyda, Mark L. Peterson, Sylvie Beaubien +2 more 2015-11-10
8497242 Processes for intermediates for macrocyclic compounds Eric Marsault, Kamel Benakli, Hamid R. Hoveyda, Mark L. Peterson, Sylvie Beaubien +2 more 2013-07-30
8440851 Spatially-defined macrocyclic compounds useful for drug discovery Eric Marsault, Kamel Benakli, Hamid R. Hoveyda, Mark L. Peterson, Sylvie Beaubien +2 more 2013-05-14
7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain Robert M. Burk 2011-05-03
7214678 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain Robert M. Burk 2007-05-08
7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain Robert M. Burk 2006-08-29
6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain Robert M. Burk 2004-11-30